Beranda › Dermatitis Atopik (Eksim) › California › Los Angeles
Uji klinis Dermatitis Atopik (Eksim) di Los Angeles, CA
11 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Menerima pesertaStudi observasional
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Menerima pesertaFase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Menerima pesertaFase 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Menerima pesertaFase 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Menerima pesertaFase 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Menerima pesertaStudi observasional
- Galderma Investigational Site 7099, Los Angeles
Uji klinis Dermatitis Atopik (Eksim) di kota lain
- New York City, NY13 studi
- Washington, DC11 studi
- San Antonio, TX10 studi
- San Diego, CA10 studi
- Birmingham, AL9 studi
- Miami, FL9 studi
- Dallas, TX8 studi
- Sacramento, CA8 studi
- Huntington Beach, CA8 studi
- Troy, MI8 studi
- Indianapolis, IN7 studi
- Pittsburgh, PA7 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker (semua jenis)74 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.